USFDA completes inspection of J B Chemicals Panoli facility with two observations
New Delhi: J B Chemicals and Pharmaceuticals said the US health regulator has completed inspection of its Panoli facility in Gujarat with two minor observations.
"The company's API manufacturing facility at Panoli, Gujarat has successfully passed periodical inspection by US Food and Drug Administration (USFDA) with two minor procedural observations," J B Chemicals and Pharmaceuticals said in a BSE filing.
The company said these observations do not impact continuity of its business and it would continue its manufacturing activities in Current Good Manufacturing Practice (CGMP) compliant manner.
"The company proposes to address these observations in next 30 days," it added.
The inspection was carried out from May 7 to May 11, 2018.
This US FDA/EU/Japan approved API facility primarily manufactures APIs for exports to EU and formulations exports to US, it said.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd